JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 40 No. 11 1913-1917
© 1999 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Egli, A.
Right arrow Articles by Schubiger, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Egli, A.
Right arrow Articles by Schubiger, P. A.

Organometallic 99mTc-Aquaion Labels Peptide to an Unprecedented High Specific Activity

André Egli, Roger Alberto, Lesley Tannahill, Roger Schibli, Ulrich Abram, Andreas Schaffland, Robert Waibel, Dirk Tourwé, Lauren Jeannin, Koen Iterbeke and P. August Schubiger

Center for Radiopharmaceutical Science, Paul Scherrer Institute, Villigen-PSI, Switzerland
Forschungszentrum Rossendorf, Institut für Radiochemie, Dresden, Germany
Eenheid Organische Chemie Vrije Universiteit Brussel, Brussel, Belgium

Correspondence: For correspondence or reprints contact: André Egli, MD, Paul Scherrer Institute, Center for Radiopharmaceutical Science, Villigen-PSI CH-5232, Switzerland.

ABSTRACT

A new peptide labeling method that uses the organometallic aquaion [99mTc (H2O)3(CO)3]+ has been developed. Methods: A selection of amino acids was labeled at different concentrations with the organometallic aquaion, and the labeling yield was determined by high-performance liquid chromatography. This investigation has shown histidine to be a very potent ligand, with specific activities of up to 6 TBq/µmol (160 Ci/µmol) ligand. Histidine derivatives have been coupled to neurotensin (8–13) (NT[8–13]) and have been labeled with the aquaion, resulting in high specific activities with (N{alpha}-histidinyl)acetic acid-NT(8–13) similar to those with histidine. Results: Histidine derivatives of NT(8–13) labeled using this approach fully retained their receptor affinity, showing KD values of all investigated NT analogs below 1 nmol/L on colon carcinoma HT29 cells. Biodistribution experiments in BALB/c mice showed complete clearance of (N{alpha}-histidinyl) acetic acid-NT(8–13) from the blood after 24 h and no unwanted accumulation in any tissue. Conclusion: The novel labeling method using the organometallic 99mTc-aquaion combines the advantage of highest specific activities with minimal functionalization of proteins and peptides under retention of biologic affinity.

Key Words: peptides • 99mTc • neurotensin • histidine




This article has been cited by other articles:


Home page
JNMHome page
M. Lipowska, H. He, E. Malveaux, X. Xu, L. G. Marzilli, and A. Taylor
First Evaluation of a 99mTc-Tricarbonyl Complex, 99mTc(CO)3(LAN), as a New Renal Radiopharmaceutical in Humans
J. Nucl. Med., June 1, 2006; 47(6): 1032 - 1040.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. J. Smith, G. L. Sieckman, N. K. Owen, D. L. Hayes, D. G. Mazuru, R. Kannan, W. A. Volkert, and T. J. Hoffman
Radiochemical Investigations of Gastrin-releasing Peptide Receptor-specific [99mTc(X)(CO)3-Dpr-Ser-Ser-Ser-Gln-Trp-Ala-Val-Gly-His-Leu-Met-(NH2)] in PC-3, Tumor-bearing, Rodent Models: Syntheses, Radiolabeling, and in Vitro/in Vivo Studies where Dpr = 2,3-Diaminopropionic acid and X = H2O or P(CH2OH)3
Cancer Res., July 15, 2003; 63(14): 4082 - 4088.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1999 by the Society of Nuclear Medicine.